CHAMPIONS ONCOLOGY, INC.
CSBR · XNASCIK 771856fmd_1E1P4NKQAX1HGZZJ2N19KTGG2JManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: May 01, 2010 to Jul 31, 2026, 65 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | 20 | 27 | 32 | 41 | 49 | 54 | 50 | 57 | 59 |
| Cost of revenue | – | – | – | 17 | 21 | 24 | 30 | 29 | 28 | 31 |
| Gross profit | – | – | – | 15 | 20 | 25 | 24 | 21 | 29 | 29 |
| Research and development | 4 | 4 | 5 | 6 | 7 | 9 | 12 | 10 | 7 | 9 |
| Selling, general and administrative | 8 | 7 | 8 | 11 | 12 | 15 | 17 | 18 | 17 | 20 |
| Total operating expenses | 22 | 22 | 27 | 34 | – | – | – | – | – | – |
| Operating income | (7) | (1) | 0 | (2) | 0 | 1 | (5) | (7) | 5 | (1) |
| Other non-operating income (expense) | (0) | (0) | (0) | (0) | 0 | (0) | (0) | 0 | 0 | 0 |
| Income before taxes | (7) | (1) | 0 | (2) | 0 | 1 | (5) | (7) | 5 | (1) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | (0) | 0 |
| Net income from continuing operations | (7) | (1) | 0 | (2) | 0 | 1 | (5) | (7) | 5 | (1) |
| Net income | (7) | (1) | 0 | (2) | 0 | 1 | (5) | (7) | 5 | (1) |
| Net income to common shareholders | – | (1) | 0 | (2) | 0 | 1 | (5) | (7) | 5 | (1) |